Kyoto University

Tottori University

Tokyo Women's Medical University

Arigen Pharmaceuticals, Inc.

Omura Toryo Co., Ltd.

Institute of Mitochondria Science, Inc.

Nai Inc.

National University Corporation Torrori University

Kanoncure, Inc.

National University Corporation Tottori University

Hiroyuki Saimoto

Kiyoshi Kita

Masaichi Yamamoto

Yoshisada Yabu

Teruo Okano

Hiroyuki Yano

Kazuo Ohashi

Masaya Nogi

Goshi Shiota

Minoru Morimoto

Shinsuke Ifuku

Yoshihiko Omura

Yoshihiro Shigemasa

Yoshiko Hoshikawa

Tomoyoshi Hosokawa

Noriko Matsumoto

Ken Daniel Inaoka

Yoshiaki Matsumi

Takayuki Tonoi

The present invention provides a novel dihydroorotic acid dehydrogenase inhibitor which is applicable to various diseases. When used as an active ingredient, a compound represented by formula (I): (wherein

Dihydroorotic and acid dehydrogenase inhibitor

The invention relates to low-molecular-weight compounds which are capable of inducing differentiation of mesenchymal stem cell into hepatocytes.

Synthesis and analysis of compounds capable of inducing differentiation of human mesenchymal stems cells into hepatocytes

Novel compounds below are useful for preventing or treating diseases caused by protozoans. At least one of a compound represented by Formula (I) (wherein, X represents a hydrogen atom or a halogen atom; Rrepresents a hydrogen atom; Rrepresents a hydrogen atom or a Calkyl group; Rrepresents &#x2014;CHO, &#x2014;C(&#x2550;O)R, &#x2014;COOR(wherein Rrepresents a Calkyl group), &#x2014;CHOH or &#x2014;COOH; and Rrepresents a Calkyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s), a Calkenyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s), or a Calkynyl group having one or more substituents on a terminal carbon atom and/or non-terminal carbon atom(s)), an optical isomer thereof, and a pharmaceutically acceptable salt is used.

Dihydroxybenzene derivatives and antiprotozoal agent comprising same as active ingredient

The present invention provides a method for producing chitin nanofibers, which includes the steps of deproteinizing a material derived from a chitin-containing organism by an alkali treatment, deashing a deproteinized integument by an acid treatment, optionally treating the deashed integument under acidic conditions, and then subjecting to a fiber-loosening treatment. The present invention also provides chitin nanofibers obtained by the method, and a composite material and a coating composition each containing the same. The present invention provides a method for producing chitosan nanofibers, which includes, in addition to the above steps, a deacetylation step and chitosan nanofibers obtained by the method, and a composite material and a coating composition each containing the same.

Method for producing chitin nanofibers, composite material and coating composition each containing chitin nanofibers, and method for producing chitosan nanofibers, composite material and coating composition each containing chitosan nanofibers

Phenol derivatives and antitrypanosoma preventive/therapeutic agent comprising the same as active ingredient

Growing community of inventors

Tottori, Japan

Hiroyuki Saimoto